Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of EGFR and KRAS mutations in Chinese patients with esophageal squamous cell carcinoma.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus - 1 Jul 2011

Liu Q-W, Fu J-H, Luo K-J, Yang H-X, Wang J-Y, Hu Y, Yang H, Bella E

Abstract excerpt

The prognosis of esophageal squamous cell carcinoma (ESCC) is poor. It is urgent to improve this situation. Epidermal growth factor receptor (EGFR)-targeted therapy possesses a promising clinical efficacy. Mutations of EGFR and V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) have been identified in esophageal carcinoma, but corresponding Chinese data are limited. So we investigated the mutation status...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Esophageal Neoplasms

Share to Esophageal Squamous Cell Carcinoma

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 21615826
DOI: 10.1111/j.1442-2050.2010.01155.x

Genes

EGFR
KRAS

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of EGFR and KRAS mutations in Chinese patients with esophageal squamous cell carcinoma.PMID 21615826Read ↗

Identification of exon 19 and 21 mutations of EGFR gene in Chinese patients with esophageal squamous cell carcinoma.Semantic proximity Read ↗

Identification of EGFR mutations in esophageal cancer.Semantic proximity Read ↗

Epidermal growth factor receptor mutations in Chinese patients with laryngeal squamous cell carcinoma.Semantic proximity Read ↗

Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas.Semantic proximity Read ↗

[Mutation status of epidermal growth factor receptor and KRAS gene in non-small cell lung cancers at Xuanwei regions of Yunnan Province].Semantic proximity Read ↗

EGFR/KRAS mutations and gefitinib therapy in Chinese NSCLC patients.Semantic proximity Read ↗

Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma.Semantic proximity Read ↗

[Mutational analysis of EGFR and K-RAS in Chinese patients with non-small cell lung cancer].Semantic proximity Read ↗

High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagus.Semantic proximity Read ↗

Correlation of epidermal growth factor receptor mutation, immunohistochemistry, and fluorescence in situ hybridization in esophageal squamous cell carcinoma.Semantic proximity Read ↗

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer.Semantic proximity Read ↗

KRAS and BRAF mutations in 203 esophageal squamous cell carcinomas: pyrosequencing technology and literature review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.